Maturity‐Onset Diabetes of the Young (MODY) With HNF1B p.Glu105Lys Mutation Achieving Significant Insulin Reduction on Tirzepatide: A Case Report

ABSTRACT This report describes the first case of maturity‐onset diabetes in young (MODY) with HNF1B mutation started administration of the dual glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1 receptor agonist, tirzepatide. A 26‐year‐old female with a 15‐year history of diabe...

Descripció completa

Dades bibliogràfiques

Autors principals:	Mihiro Sue, Mayu Watanabe, Ayumi Inoue, Akihiro Katayama, Sanae Teshigawara, Yuichi Matsushita, Masaya Takeda, Izumi Iseda, Jun Eguchi, Kazuyuki Hida
Format:	Artigo
Idioma:	Inglês
Publicat:	Wiley 2025-02-01
Col·lecció:	Clinical Case Reports
Matèries:	glucagon‐like peptide‐1 (GLP‐1) glucose‐dependent insulinotropic polypeptide (GIP) maturity‐onset diabetes in young (MODY) tirzepatide
Accés en línia:	https://doi.org/10.1002/ccr3.70173
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!